Kazakhstan

6 Vaccines Approved for Use in Kazakhstan

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: astanatimes.com
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: tass.com
Inactivated

Research Institute for Biological Safety Problems (RIBSP)

QazVac

Approved in 2 countries
3 trials in 1 country
Approval Source: reuters.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Approval Source: astanatimes.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: astanatimes.com

2 in Clinical Trials in Kazakhstan

Inactivated

Research Institute for Biological Safety Problems (RIBSP)

QazVac

Approved in 2 countries
3 trials in 1 country
Protein Subunit

Research Institute for Biological Safety Problems

QazCoVac-P

2 trials in 1 country